Current Practical Progress and Dilemmas in the Study of Premenstrual Dysphoric Disorder

Dixian Cai

doi:10.54254/2753-7048/13/20230850

Research Article

Open access

Published on 26 October 2023

Download pdf

Cai,D. (2023). Current Practical Progress and Dilemmas in the Study of Premenstrual Dysphoric Disorder. Lecture Notes in Education Psychology and Public Media,13,53-58.

Export citation

Current Practical Progress and Dilemmas in the Study of Premenstrual Dysphoric Disorder

Dixian Cai *^,1,

¹ Guizhou Medical University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-7048/13/20230850

Abstract

Premenstrual dysphoric disorder (PPD) refers to a range of symptoms which are related to the menstrual cycle, which is not only accompanied by severe physical symptoms, but often by severe emotional symptoms as well. This can have a serious impact not only on the patient's daily life, but also on the social costs. To date, however, the etiology of this disorder is not well understood and there are not very accurate, objective diagnostic methods or universally applicable special treatment options. This article aims to summaries some of the research literature relating to the etiology, diagnosis and treatment of PPD, over the last approximately 15 years, with a view to providing some insight into future research on PDD. The etiology of PDD may be related to 5-HT, GABAergic dysregulation and abnormal response of GABAA receptors to allopregnanolone. PDD’s diagnosis relies primarily on a number of scale assessments and information from medical history and physical examination. Common first and second line treatment options are antidepressants and oral contraceptives (OCs) respectively. Symptoms of PDD can also be reduced with some psychosocial treatment.

Keywords

premenstrual dysphoric disorder (PDD), menstruation, dysphoria, women’s health

View pdf

References

[1]. American College of Obstetricians and Gynecologists. (2014) Guidelines for Women’s Health Care: A Resource Manual, 4th ed.; American College of Obstetricians and Gynecologists: Washington, DC, USA, pp. 607–613.

[2]. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American College of Obstetricians and Gynecologists: Washington, DC, USA.

[3]. Epperson, C.N., Steiner, M., Hartlage, S.A., Eriksson, E., Schmidt, P.J., Jones, I., Yonkers, K.A. (2012) Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5. Am. J. Psychiatry, 169, 465–475.

[4]. Choi, S.H.; Hamidovic, A. (2020) Association Between Smoking and Premenstrual Syndrome: A Meta-Analysis. Front. Psychiatry, 11, 575526.

[5]. Schweizer-Schubert, S., Gordon, J.L., Eisenlohr-Moul, T.A., Meltzer-Brody, S., Schmalenberger, K.M., Slopien, R., Zietlow, A.L., Ehlert, U., Ditzen, B. (2021) Steroid Hormone Sensitivity in Reproductive Mood Disorders: On the Role of the GABAA Receptor Complex and Stress During Hormonal Transitions. Front. Med.7,479646.

[6]. Zorumski, C.F., Paul, S.M., Covey, D.F., Mennerick, S. (2019) Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond. Neurobiol. Stress. 11, 100196.

[7]. Halbreich, U., Tworek, H. (1993) Altered Serotonergic Activity in Women with Dysphoric Premenstrual Syndromes. Int. J. Psychiatry Med. 23, 1–27.

[8]. He, Z., Lin, S.Q. (2009) Research progress on evaluation of premenstrual syndrome and premenstrual dysphoric disorder. Chinese nursing research.13:1142-1144.

[9]. Steiner, M., Macdougall, M., Brown, E. (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 6:203–9.

[10]. Hristina, J., Åsta, C., Per, K., Johan, L., Christer, H., Anna-Lena, N. (2006) A PET study of 5-HT 1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria [J]. Psychiatry Research, 148: 185-193.

[11]. Protopopescu, X., Tuescher, O., Hong, P., Epstein, J., Root, J., Chang, L. (2008) Toward a functional neuroanatomy of premenstrual dysphoric disorder. Roanatomy of premenstrual dysphoric disorder [J]. J Affect Disord.108: 87-94.

[12]. Baller, E.B., Wei, S.M., Kohn, P.D., Rubinow, D.R., Alarcón, G., Schmidt, P.J., Berman, K.F. (2013) Abnormalities of Dorsolateral Prefrontal Function in Women With remenstrual Dysphoric Disorder: A Multimodal Neuroimaging Study [J]. A Multimodal Neuroimaging Study [J]. American Journal of psychiatry.170: 305-314.

[13]. Wyatt, K.M., Dimmock, P.W., Ismail, K.M.K., Jones, P.W., O"Brien, P.M.S. (2004) The effectiveness of GnRHa with and without ’add-back’ therapy in treating premenstrual syndrome: a meta-analysis. BJOG .111:585–93.

[14]. Halbreich, U., O'Brien, P.M., Eriksson, E., Backstrom, T., Yonkers, K.A., Freeman, E.W. (2006). Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?. Cns Drugs, 20(7), 523.

[15]. Nevatte, T., O'Brien, P.M., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C.N., Eriksson, E., Freeman, E.W., Halbreich, U., Ismail, K., Panay, N., Pearlstein, T., Rapkin, A., Reid, R., Rubinow, D., Schmidt, P., Steiner, M., Studd, J., Sundström-Poromaa, I., Yonkers, K. (2013) ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health.16:279–91.

[16]. Bluth, K., Gaylord, S., Nguyen, K., Bunevicius, A., Girdler, S. (2015) Mindfulness-based stress reduction as a promising intervention for amelioration of premenstrual dysphoric disorder symptoms. Mindfulness, 6:1292–302.

[17]. Kleinstauber, M., Witthoft, M., Hiller, W. (2012) Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis. J Clin Psychol Med Settings,19:308–19.

Cite this article

Cai,D. (2023). Current Practical Progress and Dilemmas in the Study of Premenstrual Dysphoric Disorder. Lecture Notes in Education Psychology and Public Media,13,53-58.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 4th International Conference on Educational Innovation and Philosophical Inquiries

Conference website: https://www.iceipi.org/

ISBN：978-1-83558-051-6(Print) / 978-1-83558-052-3(Online)

Conference date: 7 August 2023

Editor：Javier Cifuentes-Faura, Enrique Mallen

Series: Lecture Notes in Education Psychology and Public Media

Volume number: Vol.13

ISSN：2753-7048(Print) / 2753-7056(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).